Researchers assessed 55 first-episode drug-naive people with schizophrenia diagnoses in New Delhi, India for the predictive value of symptoms on quality of life (QOL). They found that negative symptoms have a greater impact than positive on subjective quality of life, while antipsychotics focus on primary positive and negative symptoms. “There is a need to develop a holistic approach (target non-psychotic symptoms intensively) in the disease management to prevent further long-term impairment of QOL.” The study appears in the Nordic Journal of Psychiatry.
© 2024 Mad in America Foundation
This is interesting because people are often forcibly treated for positive symptoms with drugs which give them negative symptoms.
Report comment